167 related articles for article (PubMed ID: 25467928)
21. Simultaneous integrated boost of intensity-modulated radiation therapy to Stage II-III non-small cell lung cancer with metastatic lymph nodes.
Li QS; Liang N; Ouyang WW; Su SF; Ma Z; Geng YC; Yang WG; Hu YX; Li HQ; Lu B
Cancer Med; 2020 Nov; 9(22):8364-8372. PubMed ID: 32902184
[TBL] [Abstract][Full Text] [Related]
22. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
[TBL] [Abstract][Full Text] [Related]
23. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
24. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer.
Faria SL; Souhami L; Portelance L; Duclos M; Vuong T; Small D; Freeman CR
Radiat Oncol; 2006 Nov; 1():42. PubMed ID: 17078878
[TBL] [Abstract][Full Text] [Related]
25. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.
Pollom EL; Qian Y; Durkee BY; von Eyben R; Maxim PG; Shultz DB; Gensheimer M; Diehn M; Loo BW
Clin Lung Cancer; 2016 Nov; 17(6):588-594. PubMed ID: 27378172
[TBL] [Abstract][Full Text] [Related]
27. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer.
Dirkx ML; van Sörnsen De Koste JR; Senan S
Lung Cancer; 2004 Jul; 45(1):57-65. PubMed ID: 15196735
[TBL] [Abstract][Full Text] [Related]
28. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.
Haslett K; Bayman N; Franks K; Groom N; Harden SV; Harris C; Hanna G; Harrow S; Hatton M; McCloskey P; McDonald F; Ryder WD; Faivre-Finn C
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1341-1348. PubMed ID: 33232772
[TBL] [Abstract][Full Text] [Related]
29. Salvage radiotherapy with simultaneous integrated boost in non small-cell lung cancer patients with mediastinal relapse after surgery: a pilot study.
Nicosia L; Agolli L; Reverberi C; De Sanctis V; Marinelli L; Minniti G; Di Muzio J; Valeriani M; Osti MF
Radiat Oncol; 2018 Oct; 13(1):207. PubMed ID: 30352607
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
31. Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer.
Zhang Q; Cai XW; Feng W; Yu W; Fu XL
BMC Cancer; 2022 Jan; 22(1):96. PubMed ID: 35065627
[TBL] [Abstract][Full Text] [Related]
32. DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.
Wurstbauer K; Zehentmayr F; Deutschmann H; Dagn K; Exeli AK; Kopp P; Porsch P; Maurer B; Studnicka M; Sedlmayer F
Strahlenther Onkol; 2017 Apr; 193(4):315-323. PubMed ID: 28116446
[TBL] [Abstract][Full Text] [Related]
33. Definitive radiation therapy for stage I non-small-cell lung carcinoma: institutional experience with contemporary conformal planning.
Sandhu AP; Messer K; Fuster MM; Ahmad E; Pu M; Bazhenova L; Rose M; Seagren S
Clin Lung Cancer; 2009 Nov; 10(6):433-7. PubMed ID: 19900862
[TBL] [Abstract][Full Text] [Related]
34. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
Mantel F; Müller E; Kleine P; Zimmermann M; Exner F; Richter A; Weick S; Ströhle S; Polat B; Höcht S; Flentje M
Strahlenther Onkol; 2021 May; 197(5):405-415. PubMed ID: 33725133
[TBL] [Abstract][Full Text] [Related]
35. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
36. An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy.
Ma L; Qiu B; Li Q; Chen L; Wang B; Hu Y; Liu M; Zhang L; Huang Y; Deng X; Xia Y; Lin M; Liu H
Radiat Oncol; 2018 Jul; 13(1):130. PubMed ID: 30016978
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study.
Ji K; Zhao LJ; Liu WS; Liu ZY; Yuan ZY; Pang QS; Wang J; Wang P
Br J Radiol; 2014 Mar; 87(1035):20130562. PubMed ID: 24588668
[TBL] [Abstract][Full Text] [Related]
38. Safety and palliative efficacy of single-dose 8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy.
Topkan E; Yildirim BA; Guler OC; Parlak C; Pehlivan B; Selek U
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):774-80. PubMed ID: 25752391
[TBL] [Abstract][Full Text] [Related]
39. Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy.
Chen C; Uyterlinde W; Sonke JJ; de Bois J; van den Heuvel M; Belderbos J
Radiother Oncol; 2013 Aug; 108(2):337-41. PubMed ID: 24074814
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of risk factors of radiation-induced toxicity in limited-stage small cell lung cancer treated with hypofractionated intensity-modulated radiotherapy].
Zhao JJ; Bi N; Zhang T; Wang JY; Deng L; Wang X; Chen DF; Dai JR; Wang LH
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):627-633. PubMed ID: 37462020
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]